Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
May is Mental Health Awareness Month. Nine out of ten times when someone dies by suicide, they have a diagnosable mental health condition at the time of their death. However, mental health conditions are treatable, and most people who attempt suicide go on to live healthy productive lives.
Join the American Foundation for Suicide Prevention, the largest suicide prevention organization in the United States, in celebrating Mental Health Awareness Month. By drawing attention to the importance of mental health we hope to save lives and bring hope to those affected by suicide. Taking care of your mental health is the smart thing to do.
“Mental health is as important as physical health. It impacts the way we perceive, think, feel and behave in our daily lives,” said Dr. Christine Moutier, the chief medical officer of the American Foundation for Suicide Prevention. “To help us prevent suicide, there is a role for everyone, in every community. Don’t be afraid to have a caring conversation with someone if you notice troubling changes in their behavior. This conversation just might save their life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7824851-afsp-suicide-mental-health-awareness-month/
Sullivan & Cromwell announces the launch of a multi-part video series designed to share insights from senior S&C lawyers on trends and issues impacting global financial institutions. The interviews are conducted by Lee Pacchia, Founder and CEO of Mimesis Law. In the first segment, Mitch Eitel, Managing Partner of the S&C Financial Services Group, discusses the appearance of shareholder activism in the sector, the psychology that affects the industry and burdens on financial institutions from a range of Dodd Frank changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7542531-sullivan-cromwell/
Rain, Rain and More rain! That was the story of September 17-19! Races were cancelled at all the tracks we cover! There are some up to the minute news and schedule changes announced on the show.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
PTSD treatment 1 week on former Birmingham soldier Craig Burgess talks about the changes in his PTSD post traumatic stress disorder and how all the nightmares and flashbacks have stopped after just one session with Birmingham NLP hypnotherapist Debbie Williams. Get a free hypnosis recording Stop worrying and create a wonderful life form here http://www.debbiewilliamsassociates.co.uk/home.htm
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Academy Award nominee and Golden Globe winner Sigourney Weaver stars in this emotional true story about a 1970s religious suburban housewife and mother who struggles to accept her young son Bobby being gay. What happens to Bobby is tragic and causes Mary to question her faith; ultimately this mom changes her views in ways that she never could have imagined. Premiering Saturday January 24th at 9pm/8c on Lifetime.
Academy Award nominee and Golden Globe winner Sigourney Weaver stars in this emotional true story about a 1970s religious suburban housewife and mother who struggles to accept her young son Bobby being gay. What happens to Bobby is tragic and causes Mary to question her faith; ultimately this mom changes her views in ways that she never could have imagined. Premiering Saturday January 24th at 9pm/8c on Lifetime.
Academy Award nominee and Golden Globe winner Sigourney Weaver stars in this emotional true story about a 1970s religious suburban housewife and mother who struggles to accept her young son Bobby being gay. What happens to Bobby is tragic and causes Mary to question her faith; ultimately this mom changes her views in ways that she never could have imagined. Premiering Saturday January 24th at 9pm/8c on Lifetime.
Academy Award nominee and Golden Globe winner Sigourney Weaver stars in this emotional true story about a 1970s religious suburban housewife and mother who struggles to accept her young son Bobby being gay. What happens to Bobby is tragic and causes Mary to question her faith; ultimately this mom changes her views in ways that she never could have imagined. Premiering Saturday January 24th at 9pm/8c on Lifetime.
